MARKET

HSIC

HSIC

Henry Schein
NASDAQ

Real-time Quotes | Nasdaq Last Sale

80.50
-0.16
-0.20%
After Hours: 80.50 0 0.00% 16:35 05/17 EDT
OPEN
80.64
PREV CLOSE
80.66
HIGH
81.01
LOW
79.95
VOLUME
518.41K
TURNOVER
--
52 WEEK HIGH
83.45
52 WEEK LOW
52.96
MARKET CAP
11.33B
P/E (TTM)
26.34
1D
5D
1M
3M
1Y
5Y
Zuckerman Investment Group, LLC Buys USHG Acquisition Corp, Vertiv Holdings Co, Henry Schein ...
GuruFocus News · 4h ago
HSIC vs. CNMD: Which Stock Should Value Investors Buy Now?
Zacks.com · 5h ago
Henry Schein Elects Reed V. Tuckson, M.D., FACP to Board of Directors
Henry Schein, Inc. elects Reed V. Tuckson, M.D., FACP to the Company's Board of Directors.
Business Wire · 9h ago
Henry Schein Inc. stock rises Friday, still underperforms market
Shares of Henry Schein Inc. inched 0.72% higher to $80.66 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...
marketwatch.com · 3d ago
How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre
The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on how to trade healthcare trends. Capre is the CEO and he...
Benzinga · 3d ago
Henry Schein adds $400M to share buyback program
The board of directors of Henry Schein (HSIC) has authorized the repurchase of up to $400M of the company common stock. The buyback will occur from time to time in
Seekingalpha · 3d ago
Henry Schein (HSIC) Software Module to Enhance Patient Outcome
Zacks.com · 3d ago
BRIEF-Henry Schein Announces $400 Million Increase To Share Repurchase Plan
reuters.com · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HSIC. Analyze the recent business situations of Henry Schein through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HSIC stock price target is 81.14 with a high estimate of 99.00 and a low estimate of 66.00.
EPS
Institutional Holdings
Institutions: 771
Institutional Holdings: 140.36M
% Owned: 99.76%
Shares Outstanding: 140.70M
TypeInstitutionsShares
Increased
139
4.73M
New
41
528.28K
Decreased
146
8.41M
Sold Out
46
729.67K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.54%
Healthcare Equipment & Supplies
-0.70%
Key Executives
Chairman/Director/Chief Executive Officer
Stanley Bergman
President/Vice Chairman/Director
James Breslawski
Chief Financial Officer/Executive Vice President/Director
Steven Paladino
Corporate Executive
David Brous
Corporate Executive
Brad Connett
Corporate Executive
Rene Willi
Chief Human Resource Officer/Senior Vice President
Lorelei McGlynn
Executive Vice President/Chief Administrative Officer/Director
Gerald Benjamin
Corporate Executive
Bridget Ross
Executive Vice President/Director
Mark Mlotek
Senior Vice President/Chief Technology Officer
Christopher Pendergast
Senior Vice President/General Counsel
Walter Siegel
Senior Vice President/Secretary
Michael Ettinger
Senior Vice President
Jonathan Koch
Senior Vice President
James Mullins
Senior Vice President
Michael Racioppi
Lead Director/Independent Director
Philip Laskawy
Independent Director
Mohamad Ali
Independent Director
Barry Alperin
Independent Director
Paul Brons
Independent Director
Deborah Derby
Independent Director
Shira Goodman
Independent Director
Joseph Herring
Independent Director
Kurt Kuehn
Independent Director
E. Dianne Rekow
Independent Director
Anne Margulies
Independent Director
Carol Raphael
Independent Director
Elizabeth Rekow
Independent Director
Bradley Sheares
No Data
  • All
  • Financials
  • Insiders
More
About HSIC
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.

Webull offers kinds of Henry Schein, Inc. stock information, including NASDAQ:HSIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSIC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HSIC stock methods without spending real money on the virtual paper trading platform.